Kandelia

Saturday, February 20, 2010

金線蓮 (Jewel Orchid) 開花了!

這是去年二月在社子花市買的金線蓮 (Jewel Orchid),

金線蓮 Jewel Orchid (6 Feb. 2009)

今年, 金線蓮一共長出了二支花...

好多好多花苞, 從下而上開始盛開! (20 Feb. 2010)

第二支的花期較晚! (20 Feb. 2010)

白色的花, 有黃色的花蕊! (20 Feb. 2010)

特寫一下! (20 Feb. 2010)

Thursday, February 18, 2010

Google Map of My Kiva's Loans

今天早上把已經歸還到我的 Kiva 帳戶的錢又借出去後, 發現一個 Kiva 的新功能, 會將你所有曾經借出去的國家, 繪製成一張如下的 Google 地圖, 讓我們更清楚地知道自己曾經借錢給哪些國家!

Tuesday, February 16, 2010

台灣阿嬤 Phalaenopsi amabilis

去年過年買的台灣阿嬤(Phalaenopsi amabilis) 開始開花了 !

(10 Feb. 2010)

總共有10個花苞呢! (10 Feb. 2010)

ama 很漂亮吧! (10 Feb. 2010)

ama 特寫! (10 Feb. 2010)

Tuesday, February 09, 2010

黃帝內經素問四氣調神大論篇第二

今天早上在噗浪上分享到四氣調神大論篇第二的最後一段, 之後便把通篇整理到這邊和大家分享。

四氣調神大論篇第二

From Chinese Medicine

春三月, 此為發陳。天地俱生, 萬物以榮, 夜臥早起, 廣步于庭, 被髮緩行, 以使志生, 生而勿殺, 予而勿奪, 賞而勿罰, 此春氣之應, 養生之道也; 逆之則傷肝, 夏為實寒變, 奉長者少。

夏三月, 此為蕃秀。天地氣交, 萬物華實, 夜臥早起, 無厭于日, 使志勿怒, 使華英成秀, 使氣得泄, 若所愛在外, 此夏氣之應, 養長之道也; 逆之則傷心, 秋為痎瘧, 奉收者少, 冬至重病。

秋三月, 此謂容平, 天氣以急, 地氣以明, 早臥早起, 與雞俱興, 使志安寧, 以緩秋刑, 收斂神氣, 使秋氣平, 無外其志, 使肺氣清, 此秋氣之應, 養收之道也; 逆之則傷肺, 冬為飧泄, 奉藏者少。

冬三月, 此為閉藏。水冰地坼, 勿擾乎陽, 早臥晚起, 必待日光, 使志若伏若匿, 若有私意, 若已有得, 去寒就溫, 無泄皮膚, 使氣極奪。此冬氣之應, 養藏之道也; 逆之則傷腎, 春為痿厥, 奉生者少。

天氣清淨, 光明者也, 德藏不止, 故不下也。天明則日月不明, 邪害空竅。陽氣者閉塞, 地氣者冒明, 雲霧不精, 則上應白露不下。交通不表, 萬物命故不施, 不施則名木多死。惡氣不發, 風雨不節, 白露不下, 則菀藁不榮。賊風數至, 暴風數起, 天地四時不相保, 與道相失, 則未央滅絕。唯聖人從之, 故身無奇病, 萬物不失, 生氣不竭。

逆春氣則少陽不生, 肝氣內變。逆夏氣則太陽不長, 心氣內洞。逆秋氣則太陰不收, 肺氣焦滿。逆冬氣則少陰不藏, 腎氣獨沉。

夫四時陰陽者, 萬物之根本也。所以聖人春夏養陽, 秋冬養陰, 以從其根; 故與萬物沉浮于生長之門, 逆其根則伐其本, 壞其真矣。故陰陽四時者, 萬物之終始也; 生死之本也; 逆之則災害生, 從之則苛疾不起, 是謂得道。道者, 聖人行之, 愚者佩之。從陰陽則生, 逆之則死; 從之則治, 逆之則亂。反順為逆, 是為內格。

是故聖人不治已病, 治未病; 不治已亂, 治未亂, 此之謂也。夫病已成而後藥之, 亂已成而後治之, 譬猶渴而穿井, 鬪而鑄錐, 不亦晚乎 ?

閱讀黃帝內經素問上古天真論篇第一

Sunday, February 07, 2010

〔自由時報 2010/02/05 記者王昶閔台北報導原始新聞連結〕

國內中藥材有九成從中國進口，最近有本土中藥製造廠發現，部分進口中藥材中的有效成分竟被抽取盜走，從藥材外觀上，根本無法察覺，一般消費者不察，可能成為冤大頭。

勝昌製藥股份有限公司技術長李威著表示，該公司從中國進口用來製作中藥濃縮製劑的麻黃與芍藥，經逐批檢驗，部分驗出有效成分不足，例如麻黃中的麻黃鹼、芍藥中的牡丹酚、芍藥?，後來才知道，進口前，已被中國當地農民以浸泡酒精的方式抽取走。

李威著表示，以麻黃為例，該公司去年進口十批中，約兩批被檢出有問題，每批五到十公噸。更常見的詐欺手法，是透過不當手段為藥材重量「灌水」，騙取較高賣價。

高雄醫學大學天然藥物研究所講座教授吳永昌表示，中國進口中草藥過去有不肖業者添加鉛，近年還發現浸泡了鹽水，民眾吃多了對腎臟有害。甚至還有業者在藥材紙箱中，偷灌水泥，各種離譜現象實在匪夷所思。

最近已有國內藥廠在花蓮打造全台最大的中藥材生產基地，一開始以種植丹參、當歸為主。

李威著估計，國內進口丹參一年約一百五十噸到三百噸，但清一色是乾貨，有效成分較低，農藥殘毒、重金屬含量也有疑慮，國產新鮮丹參，安全性大幅提高，其有效成分「丹參酮」與「丹參酸」也是中國乾燥丹參的五到九倍。

中醫師張成國表示，丹參有調經止痛、活血祛瘀功效，有助治療不孕症與心血管疾病，但不能跟抗凝血劑併服，懷孕婦女使用過量則可能流產。
　

Friday, February 05, 2010

Ernest's Paintings

每個星期六帶 Ernest 去彤采美術上畫畫課後, 我總是習慣用數位相機記錄每個星期的作品, 最近慢慢開始放到 Picasa 的網路相簿中...

Wednesday, February 03, 2010

Report: 中華白海豚的解剖結果

剛剛在網路上逛保育新聞, 看到一則有關中華白海豚的解剖結果報告, 和這邊整理的幾則新聞有關, 於是就轉貼過來, 方便大家彙整:

2009/09/25 於苗栗新埔漁港發現死亡擱淺之中華白海豚的解剖結果
【2009/10/5】

本（98）年9月25日於苗栗新埔漁港民眾發現死亡擱淺之中華白海豚，送交台中國立科學博物館進行解剖研究，初步結果如下：

一、發現時間: 2009/9/25

二、剖檢日期: 2009/9/25

三、性別: 母，成年，248 公分

四、外觀:

　1. 明顯過度消瘦

　2. 下顎與尾部有多處針孔樣病灶

　3. 上下顎牙齒皆嚴重磨損

五、剖檢紀錄:

　1. 心包囊積液

　2. 左心室與大動脈血栓

　3. 肺與第一胃表面纖維素樣沾黏

　4. 氣管內有多量水分，肺切開有多量泡沫

　5. 肺門淋巴結有出血點

　6. 脾臟蒼白並有深紅色斑點

　7. 肝切面偏褐色

　8. 乳腺實質堅硬有分泌乳汁

六、死亡原因:

　1. 細菌性胸膜肺炎

　2. 左心室大動脈血栓併肥厚性心肌病

　3. 溺斃

Saturday, January 09, 2010

黃帝內經素問上古天真論篇第一

這是從去年 11/25 起, 每天在噗浪上, 和噗友分享一小段黃帝內經原文, 終於在今天把素問上古天真論篇第一分享完畢, 我把它整理到這邊和大家分享。

黃帝內經素問上古天真論篇第一

昔在黃帝, 生而神靈, 弱而能言, 幼而徇齊, 長而敦敏, 成而登天。

乃問于天師曰: 余聞上古之人, 春秋皆度百歲, 而動作不衰; 今時之人, 年半百而動作皆衰者。時世異耶? 人將失之耶?

岐伯對曰: 上古之人? 其知道者, 法于陰陽, 和于術數, 食飲有節, 起居有常, 不妄作勞, 故能形與神俱, 而盡終其天年, 度百歲乃去。

今時之人不然也, 以酒為漿, 以妄為常, 醉以入房, 以欲竭其精, 以耗散其真, 不知持滿, 不時御神, 務快其心, 逆于生樂, 起居無節, 故半百而衰也。

夫上古聖人之教下也, 皆謂之虛邪賊風避之有時, 恬淡虛無, 真氣從之, 精神內守, 病安從來。是以志閑而少欲, 心安而不懼, 形勞而不倦, 氣從以順, 各從其欲, 皆得所願。故美其食, 任其服, 樂其俗, 高下不相慕, 其民故曰樸。是以嗜欲不能勞其目, 淫邪不能惑其心, 愚智賢不肖, 不懼于物, 故合于道。所以能年皆度百歲而動作不衰者, 以其德全不危也。

帝曰: 人年老而無子者, 材力盡邪? 將天數然也?

岐伯曰: 女子七歲腎氣盛, 齒更髮長。二七而天癸至, 任脈通, 太冲脈盛, 月經以時下, 故有子。三七腎氣平均, 故真牙生而長極。四七筋骨堅, 髮長極, 身體威壯。五七陽明脈衰, 面始焦, 髮始墮。六七三陽脈衰于上, 面皆焦, 髮始白。七七任脈虛, 太冲脈衰少, 天癸竭, 地道不通, 故形壞而無子也。

丈夫八歲腎氣實, 髮長齒更。二八腎氣盛, 天癸至, 精氣溢瀉, 陰陽和, 故能有子。三八腎氣平均, 筋骨勁強, 故真牙生而長極。四八筋骨隆盛, 肌肉滿壯。五八腎氣衰, 髮墬齒槁。六八陽氣衰竭於上, 面焦, 髮鬢頒白。七八肝氣衰, 筋不能動, 天癸竭, 精少, 腎臟衰, 形體皆極。八八則齒髮去。

腎者主水, 受五臟六腑之精而藏之, 故五臟盛, 乃能瀉。
今五臟皆衰, 筋骨解墮, 天癸盡矣, 故鬢髮白, 身體重, 行步不正, 而無子耳。

帝曰: 有其年已老, 而有子者, 何也?

岐伯曰: 此其天壽過度, 氣脈常通, 而腎氣有餘也。此雖有子, 男子不過盡八八, 女子不過盡七七, 而天地之精氣皆竭矣。

帝曰: 夫道者年皆百歲, 能有子乎?

岐伯曰: 夫道者能却老而全形, 身年雖壽, 能生子也。

黃帝曰: 余聞上古有真人者, 提挈天地, 把握陰陽, 呼吸精氣, 獨立守神, 肌肉若一, 故能壽敝天地, 無有終時, 此其道生。

中古之時, 有至人者, 淳德全道, 和于陰陽, 調于四時, 去世離俗, 積精全神, 游行天地之間, 視聽八遠之外, 此蓋益其壽命而強者也。亦歸于真人。

其次有聖人者, 處天下之和, 從八風之理, 適嗜欲于世俗之間, 無恚嗔之心, 行不欲離于世, 被服章, 舉不欲觀于俗, 外不勞形於事, 內無思想之患, 以恬愉為務, 以自得為功, 形體不敝, 精神不散, 亦可以百數。

其次有賢人者, 法則天地, 象似日月, 辨列星辰, 逆從陰陽, 分別四時, 將從上古合同于道, 亦可使益壽而有極時。

繼續閱讀黃帝內經素問四氣調神大論篇第二

Wednesday, December 16, 2009

acupuncture

2009/11/25

來自 London 的一家球鞋店, 竟然叫做 acupuncture !

好神奇!

http://www.acupuncturefootwear.com.hk/index.asp

acupuncture 品牌是在 1993 年由創辦人 PHILIP 及其友人在倫敦 SOHO 後街小巷裡開設一間售賣懷舊衣飾及運動鞋的細小店舖開始。在 PHILIP 全面接管店舖後，便以玩票性質設計及生產揉合七十年代球鞋款式的鞋履在店舖裡銷售，甫一推出便在日本及英國賣出了 5,000 雙 ...
　

Monday, December 14, 2009

News: Swine-flu bribe fever!

原始新聞連結

U.N.'s H1N1 scientists linked to companies making vaccine
Posted: December 07, 2009
9:53 pm Eastern

By Chelsea Schilling
© 2009 WorldNetDaily

World Health Organization scientists are suspected of accepting secret bribes from vaccine manufacturers to influence the U.N. organization's H1N1 pandemic declaration, according to Danish and Swedish newspapers.

Meanwhile, pharmaceutical profits from swine-flu-related drugs have soared – with earnings between $10 billion and $15 billion in 2009, investment bank JPMorgan estimates.

As WND reported, WHO Director General Margaret Chan initially raised the influenza pandemic alert to its second-highest level in May – but evidence reveals the agency may have made it easier to classify the flu outbreak as a pandemic by changing its definition to omit "enormous numbers of deaths and illness" just prior to making its declaration.

The world was gripped with fears of swine flu as the alert increased from Phase 5 to Phase 6, the highest level. Immediately, pharmaceutical companies began working to develop vaccines, and countries tailored their responses to address the situation.

Shots frighten you? Be sure to get "SCARY MEDICINE: Exposing the dark side of vaccines"

Danish newspaper Information reported that when Chan raised the level of pandemic alert on June 11, the declaration meant substantial economic benefits for the pharmaceutical industry – especially since many countries have contracts with major drug companies and are required to purchase vaccines in the event of a pandemic. Swedish newspaper Svenska Dagbladet echoed Information's report.

"Many of the apparently impartial researchers the WHO uses, however, are paid by the companies that produce vaccines," states a translated version of the Information article, "Strong lobbying behind WHO resolution on mass vaccination."

One expert in a WHO H1N1 advisory group, Dr. Albert Osterhaus, has been subject to a Dutch government investigation. The government convened a crisis meeting after an article in Science magazine indicated that Osterhaus has financial interests in several pharmaceutical companies.

Osterhaus, known as "Dr. Flu," is the head of the department of virology at the Erasmus Medical Center, University of Rotterdam. According to a European Commission Research website, Osterhaus is co-founder of two biotech companies and promotes vaccines as solutions for pandemics.

Another expert who advises WHO on vaccines, Dr. Frederick Hayden, is described as a flu-research coordinator from the Wellcome Trust in London.

However, according to the report, Hayden also serves as a "paid adviser" for pharmaceutical companies Roche, RW Johnson, SmithKline Beecham and Glaxo Wellcome.

WHO expert Dr. Arnold Monto is also purportedly a paid consultant for MedImmune (a company that produces nasal flu vaccine), Glaxo Wellcome and ViroPharma. However, WHO's Strategic Advisory Group of Experts never divulged those ties, according to the report.

The newspaper also states that numerous pharmaceutical companies maintain an active presence during WHO advisory group meetings, with representatives listed as "observers."

Professor Tom Jefferson, epidemiologist at the Cochrane Center in Rome, told Information he believes the researchers' dual roles are problematic, and he noted the WHO's emphasis on drugs rather than proper hygiene habits.

"The WHO's latest recommendation on the control of pandemic influenza has frequent washing of hands mentioned twice," he said. "Vaccines and antivirals are, however, mentioned 24 and 18 times. Why would an international public-health agency focus on much more expensive interventions, such as vaccines and medication, when it is not proven that they work?"

Jefferson said washing one's hands is the only proven method of flu prevention.

Wolf Dieter Ludwig, head of the drug commission of the German Medical Association, told Der Spiegel he has no doubt pharmaceutical companies have been seeking to capitalize off what he called a "nonexistent threat."

WHO spokesman Gregory Hartl told Information it's natural to allow representatives of the pharmaceutical industry to participate in WHO meetings.

"Everybody has something to contribute in this process – industry, [nongovernmental organizations] and professional players – so we can gather all information," he said. "They cannot vote. They have no influence on the outcome, and they can only speak when they are asked. We make vaccine recommendations, so we need knowledge about what is required to produce a vaccine. Only the manufacturers have that knowledge."

According to the report, WHO does not publicize information about advisers' financial ties to the pharmaceutical industry.

"All staff must sign the declaration of conflicts of interest, so we are clear about their background," Hartl said. "But again, Frederick Hayden is the best influenza virologist in the world, so if you want to know how influenza behaves, you ask Fred Hayden."

Asked why WHO doesn't publish the advisers' financial ties to drug companies, he replied, "I'm not sure why we didn't publish it. I can't answer that. … It is possible that we will look at a code of disclosure of financial information, but I cannot promise anything."

He continued, "WHO has a system that guarantees independence. … We do not let anything or anyone influence us."

Louise Voller, journalist at the Danish daily and co-author of the report, told Russia Today, "The biggest problem seems to be that we don't know enough. There's not enough transparency on financial disclosure on the expert groups used by WHO. ... Scientists who appear to be independent are also hired consultants working for the same pharmaceutical companies who produce the vaccines. This is clearly an issue that needs to be taken care of."

Voller said she does not expect that the WHO will publish the financial disclosures on its experts unless public pressure is put on the organization.

Asked whether any solid investigations are being conducted to explore the allegations, she replied, "Not currently. I don't think so. ... [I]t has to be public what is going on in these meetings and what is going on in these expert groups. Who are the people working for WHO? And who else are they working for?"

According to Voice of America, Keiji Fakuda, WHO director general on pandemic influenza, refuted claims that WHO is in collusion with the pharmaceutical industry. He also noted that 150 million doses of H1N1 vaccine have been distributed in 40 countries.

Meanwhile, WHO reports the global H1N1 death toll at 8,768 as of Dec. 4.

According to estimates from the U.S. Centers for Disease Control and Prevention, between 2,500 and 6,100 Americans died from swine flu between April and Oct. 17 this year.

However, the CDC also reports that during a typical U.S. winter, normal seasonal flu strains result in an average of 200,000 hospitalizations and 36,000 American deaths – roughly 10 times the current swine-flu death rate.

Leading epidemiologists are now predicting the pandemic may rank as the mildest on record.

Tuesday, December 01, 2009

News: Taiwan and China

Taiwan and China

By PHILIP BOWRING
Published: October 6, 2009

HONG KONG - Taiwan’s position as a de facto independent state seems to be morphing very slowly toward the “one country, two systems” status of Hong Kong. The process is not irreversible but the sentiments of those of mainland origin in the governing Nationalist Party, along with the self-interest of business groups and a widespread sense of economic vulnerability are all pushing the island toward accommodation with Beijing.

The trend could mean an erosion in the support Taiwan gets, albeit erratically, from the United States and Japan.

The most striking evidence of a desire to please Beijing — at the expense of the liberal values which have gained Taiwan much praise in recent years — was the denial of entry to the exiled Uighur leader Rebiya Kadeer. This was done in the name of “national interest,” apparently linked to the finalization, expected soon, of a memorandum of understanding on cross-strait financial links.

For sure, the memorandum would be a major advance, enabling banks in particular to escape the confines of Taiwan, with its low growth and surplus savings, for the fast-growing mainland. And it would bring more mainland capital to local stocks and property. But the government of President Ma Ying-jeou may have forgotten that Taiwan’s national interest as an independent state, albeit one that may one day merge with the mainland, sometimes requires sacrifices. The degree of autonomy that Rebiya Kadeer has been seeking for Uighurs is a fraction of that enjoyed by Taiwan or even Hong Kong.

There is real benefit in increasing cross-straits financial links. Banks have much to gain by being able to service clients in Taiwan with business on the mainland. Cross-straits links may attract service industries to Taiwan that would otherwise go to Hong Kong. Mainland tourism is also an unqualified plus.

But Taiwan seems to be talking itself into believing that it is even more dependent on the mainland than need be the case. The island would be a more attractive place for foreign business if it removed the many restrictions that exist to protect local businesses, or stem simply from bureaucracy and outdated rules. Tax issues also tend to keep business offshore while not preventing a huge outflow of capital. The Ma government has made progress on these issues, but they get scant attention compared to cross-straits ones.

It is easy to blame a lackluster economy on being unable to take full advantage of the mainland. But in reality, Taiwan is a mature economy with minimal growth in its work force. Like Japan, its problems lie with an inefficient domestic services sector, not with an inventive export-manufacturing one.

Dependence on China is often overstated. While 40 percent of Taiwan’s exports go there, more than half are components for globally traded items like laptops and cellphones made by Taiwanese companies and then re-exported from China. The dependence is self-imposed for profit reasons, which may be shifting as mainland costs rise. There are alternatives.

Worrying too for friends of Taiwan’s liberal democracy is the vengeance being meted out to the opposition by powerful supporters of the governing Nationalist Party, or KMT. Former president Chen Shui-bian was found guilty of corruption and his conduct has left the opposition Democratic Progressive Party demoralized and frustrated. But given the pervasiveness of money politics and the past reputation of the Nationalists for corruption, the life sentence for Chen is extreme. Now, in the name of fighting corruption, there is talk of a witch-hunt against other members of the Chen administration. To some this smacks of an attempt by pro-unification elements to please Beijing by demonizing Chen, who supported independence and who suffered much in the cause of breaking the KMT’s authoritarian hold on power.

None of this is likely to help Taiwan’s relations with its main supporter, the United States. Chen upset a natural ally in George W. Bush by needlessly provoking Beijing in an attempt to score political points at home. Now the KMT seems to have gone to the other extreme. Taiwan has long disappointed Washington with unwillingness to spend money on arms. Now it may sense a lack of willingness to pay an economic price for the principles of independence and liberalism it claims to stand for. President Ma remains well-regarded abroad, but his grip on the KMT is uncertain. Taiwan lacks a strategic view of itself and how to balance relations with the Chinese mainland, the United States and the global economy with liberal democracy and de facto independence.

臺灣與中國大陸改善關係是福是禍？

新紀元周刊陳邁克編譯

獨立作家包雲(Philip Bowring)十月七日在《紐約時報》發表〈臺灣與中國〉(Taiwan and China)一文。作者認為，馬英九政府為了經濟利益，對北京過度讓步，可能危及臺灣的民主自由。

馬英九對北京過度讓步

包雲表示，臺灣作為一個實際上獨立的國家，已經逐漸接近香港的一國兩制。國民黨的親共趨向、以私利為中心的商業團體、還有經濟上脆弱的普遍感覺，一起把臺灣推向迎合北京的道路上。

以國家利益為由拒絕維族領袖熱比婭入境，是臺灣取悅北京最明顯的證據，這顯然與兩岸即將簽訂的金融合作備忘錄有關。

即使合作備忘錄對臺灣有利，但馬英九政府可能忘記，臺灣作為事實上獨立的國家，有時候需要犧牲國家利益。熱比婭替維吾爾人爭取的自治權，可能只是臺灣甚至香港所擁有的一部分。

兩岸增加金融交流縱使具有實質利益，但臺灣相信自己需要依賴中國的程度，似乎超過事實。如果臺灣能鬆綁保護本地企業的限制，改變官僚制度和過時的法規、稅法，就能吸引更多外資。馬英九政府在這些方面不是沒改進，而是被兩岸議題淹沒。

前臺灣總統陳水扁試圖在臺灣獲取政治上的高分，因而激怒北京、困擾美國。現在，國民黨似乎走向另一個極端。臺灣對自身缺乏戰略眼光，來平衡其與中國大陸、美國，以及在自由民主和事實上獨立的條件下，與全球經濟的關係。

臺灣受制中共

全球安全網站(GlobalSecurity.org)在五月十一日發表的資深研究員史奈德(Scott A. Snyder)的文章〈臺灣逐漸惡化的戰略地位與兩岸關係〉(Taiwan's Deteriorating Strategic Position and Cross-Strait Relations)，就已經表示，儘管兩岸關係改善、經濟合作增加，但在中共持續擴軍的情況下，臺灣的戰略地位卻日益惡化。臺灣同時需要美國持續供應武器以及在政治上的支持，才能保有必要的空間及政治力量，而不受制於中共。

馬英九上任一年以來，中臺雙方於四月份在南京召開第三次「江陳會」，會中簽訂三項協議以加強兩岸經濟合作。然而，兩岸恢復對話對臺灣逐漸惡化的長期戰略地位而言，並無多大幫助。臺灣的戰略地位之所以惡化，起因於中共在全球政治、經濟和軍事上擁有越來越大的影響力。

對於馬英九的政治成就，以及臺灣開展有效的國際經濟成長策略的能力而言，兩岸關係的未來發展扮演舉足輕重的角色。

兩岸相互依賴性增加

馬英九政府藉由推行「大三通」與中國大陸建立較多經濟上的相互依賴性，顯示出該政府較願意接受「與大陸建立較緊密的經濟關係對臺灣有顯著利益，但不表示在政治上有較緊密的整合」這樣的倡議。此外，他也希望，與大陸加強合作可以減少中共對臺灣擴展經貿外交的封殺，進而獲取較多的區域或全球性經濟契機。

馬英九倡議與胡錦濤背書的「兩岸經濟合作架構協議」(Economic Cooperation Framework Agreement，ECFA)，可能增加彼此在經濟上的相互依賴性，也可能減少中共在政治上對臺灣與東南亞鄰國建立自由貿易協定的干預，否則，臺灣的競爭地位可能因此而蒙受損失。

然而，有些人認為，在經濟上與中國更加相互依賴，以獲取更多區域性經濟契機的策略，在某些方面構成危險。第一，民進黨認為，馬英九為了短期利益對北京做出讓步，這會削弱臺灣在政治上保持不受北京支配的長期能力。第二，這種策略會增加北京的影響力，因為此一策略的成功與否，取決於中共是否接受臺灣在維持某種程度的「國際空間」上擁有合法利益。第三，兩岸加強經濟整合會使北京更容易實行「一國兩制」，儘管大多數臺灣人反對這種制度。

臺灣戰略地位持續惡化

中共不斷擴充軍備也使臺灣的長期戰略地位持續惡化。儘管美國基於《臺灣關係法》，保證臺灣擁有自我防衛、不受中共攻擊或恫嚇的戰力。然而，中共持續進行軍事現代化，卻使兩岸軍事平衡逐漸向中共傾斜。

正當美中協商對於全球穩定性的管理越形重要之際，臺灣日益關注美國最終是否會屈服於中共壓力，而減少出售臺灣自衛所需的武器。臺灣不但需要美國持續供應武器，也需要美國在政治上的持久支持，以確保臺灣擁有必要的空間及政治力量，而不完全依賴中共。
　